Morningside Venture Partners Investor

Morningside Venture Partners focuses on partnering with talented entrepreneurs to develop the next wave of truly great companies.
Technology:
Cell_Therapies
Industry:
Longevity Industry 2022
Headquarters:
New York, New York, United States
Founded Date:
2018-01-01
Investor Type:
Angel Group, Venture Capital
Investment Stage:
Early Stage Venture, Seed, Venture
Number Of Exits:
7
Register and Claim Ownership